Skip to main content
Article thumbnail
Location of Repository

Trends in bronchoscopic findings over a decade

By Maria Agius, Stephanie Falzon, Josef Micallef, Alexia Meli and Stephen Montefort


The incidence of lung cancer in Maltese males is higher than that in females. However trends in Maltese and other foreign populations indicate a substantial recent increment in the diagnosis of lung cancer in women. In this retrospective study we report the trends seen along the last decade in bronchoscopic findings of bronchoscopies carried out by one hospital firm in order to try and reflect the practices and results of this important endoscopic investigation on the incidence, diagnosis and treatment of lung malignancies in Malta

Topics: Lungs -- Cancer -- Malta, Bronchoscopy -- Malta, Lungs -- Cancer -- Treatment, Lungs -- Cancer -- Diagnosis
Publisher: Malta Medical Journal
Year: 2009
OAI identifier:
Provided by: OAR@UM

Suggested articles


  1. (1999). Allelic losses at chromosome 8p21–23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res.
  2. Analysis of K-Ras gene mutation in lung carcinomas: correlation with gender, histological subtypes and clinical outcome. doi
  3. (1997). Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. doi
  4. (2002). Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. doi
  5. (2006). DNA Adducts of Tobacco Smoke Carcinogens.
  6. (1999). Do patients with squamous cell carcinoma or adenocarcinoma of the lung have different smoking histories? Rev Mal Respir.
  7. (2000). Estimating the world cancer burden Globocan doi
  8. et al Gender differences in non-small lung cancer survival: an analysis of 4618 patients diagnosed between 1997-2002. Ann. Thorac Surg.
  9. et al Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.
  10. (2008). Extensive metabolic activation of the tobacco-specific carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in smokers. Cancer Epidemiol Biomarkers Prev. doi
  11. Fibreoptic bronchoscopy-indications, results and pick-up rates of various sampling modalities.
  12. Gender and smoking-related risk of lung cancer. The Copenhagen center for prospective population studies.
  13. Gender differences in genetic susceptibility for lung cancer. Lung Cancer. doi
  14. Implications and prognostic value of K-ras mutation for earlystage lung cancer in women.
  15. (1997). International differences in epidemiology of lung adenocarcinoma. Lung Cancer. doi
  16. Liver disease in women. Alcohol, autoimmunity and gallstones.
  17. Lung cancer in Malta – A pilot study of characteristics and incidence.
  18. Lung cancer in US women: a contemporary epidemic. doi
  19. Lung cancer in women, age, smoking, histology, performance status, stage, initial treatment and survival, Population-based stody of 20561 cases. doi
  20. (2003). Lung cancer mortality in European regions [1955– 1997]. Ann Oncol.
  21. Molecular and Genetic Aspects of Lung Cancer.
  22. (1999). Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. doi
  23. (2007). Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis. doi
  24. Re: environmental tobacco smoke, genetic susceptibility and risk of lung cancer in no-smoking women. doi
  25. (1997). Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. doi
  26. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. doi
  27. Sex differences in presentation, management and prognosis of patients with non-small cell lung carcinoma. doi
  28. smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. doi
  29. (1997). The changing cigarette. Prev Med. doi
  30. (2003). The changing epidemiology of lung cancer in Europe. Lung Cancer. doi
  31. (1999). The tobaccospecific carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is a ß-Adrenergic Agonist and stimulates DNA synthesis in lung adenocarcinoma via ß-adrenergic receptor-mediated release of arachidonic acid. Cancer Res.
  32. Tobacco smoke carcinogens and lung cancer. doi
  33. What’s new in the epidemiology of lung cancer: the female aspect. doi
  34. (1997). Women and lung cancer: waiting to exhale. Chest.
  35. (1981). Women and small cell lung cancer: social characteristics, medical history, management and survival: a retrospective study of all the male and female cases diagnosed in Bas-Rhin [Eastern France] between doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.